BIONTECH : UBS sticks Neutral

marketscreener.com - 27 Nov 2023
Eliana Merle from UBS retains his Neutral opinion on the stock. The target price has been revised downwards and is now set at USD 110 as compared to USD 153 ...

Stocks With Rising Relative Strength: BioNTech ADR

Investor's Business Daily - 22 Apr 2025
Stocks With Rising Relative Strength: BioNTech ADR ...

BioNTech Earnings: COVID Vaccine Giant Sets Critical Q1 2025 Financial Results Date

Stock Titan - 22 Apr 2025
BioNTech Earnings: COVID Vaccine Giant Sets Critical Q1 2025 Financial Results Date ...

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

TradingView - 22 Apr 2025
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 ...

Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine

PharmaTimes - 22 Apr 2025
Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine ...

BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations

Yahoo Finance - 21 Apr 2025
BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations ...

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | BNTX Stock News

GuruFocus - 22 Apr 2025
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | BNTX Stock News ...

BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific

Fierce Biotech - 28 Mar 2025
BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific ...

BioNTech’s Bispecific Elicits Treatment Response in Majority of SCLC Patients

BioSpace - 28 Mar 2025
BioNTech’s Bispecific Elicits Treatment Response in Majority of SCLC Patients ...

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

Bluefield Daily Telegraph - 22 Apr 2025
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 ...

FDA puts clinical hold on BioNTech’s malaria vaccine trial

Clinical Trials Arena - 05 Mar 2025
FDA puts clinical hold on BioNTech’s malaria vaccine trial ...

BioNTech guides for worse-than-expected 2025 revenue decline

Reuters - 10 Mar 2025
BioNTech guides for worse-than-expected 2025 revenue decline ...

BioNTech's PD-L1/VEGF-A impresses in SCLC as bispecific battle heats up

FirstWord - 28 Mar 2025
BioNTech's PD-L1/VEGF-A impresses in SCLC as bispecific battle heats up ...

Fierce Pharma Asia—Pharma CEOs meet Xi Jinping; Trump's tariffs; BioNTech's bispecific data

Fierce Pharma - 04 Apr 2025
Fierce Pharma Asia—Pharma CEOs meet Xi Jinping; Trump's tariffs; BioNTech's bispecific data ...

Gaithersburg-Based Novavax’s COVID-19 Vaccine Shows Lower Side Effects Than Pfizer-BioNTech

The MoCo Show - - 17 Apr 2025
Gaithersburg-Based Novavax’s COVID-19 Vaccine Shows Lower Side Effects Than Pfizer-BioNTech ...

Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024

PR Newswire - 05 Dec 2024
Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024 ...

BioNTech